Three in four people first diagnosed with liver disease during emergency hospital admission, major new study finds
Three in four people are first diagnosed with liver disease during an emergency hospital admission, according to a major national study published in the European Journal of Internal Medicine . The study found that almost 60% of these patients die within five years of...
Update on trials for future treatment of biliary atresia
As many of the young people and families we support are affected by biliary atresia, we’d like to update you on two pieces of research in this area: Ipsen evaluation of Bylvay Ipsen have announced the results of their Phase III BOLD trial evaluating Bylvay...
The EMERALD study
Trial status: active not recruiting Trial ID: NCT06823713 What is the EMERALD study? EMERALD is a clinical trial designed to test if a new treatment called RTX001 is safe, easy to cope with, and works well for people suffering from decompensated liver cirrhosis. The...
New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease
A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to the Commission, working alongside...